Oncoheroes Biosciences, the first company exclusively focused on the development of innovative medicines to treat cancer in children and adolescents, signed an agreement with Dreamers Startup Ventures to invest up to $1.1 million in the coming months. The biotech company is currently raising a 5 million preserie A round.
It is an important financial achievement to continue working on the clinical development plan for volasertib, its first asset in-licensed from Boehringer Ingelheim.
Oncoheroes is a CataloniaBio & HealthTech member based in Barcelona and Boston.
Photo: Cesare Spadoni, co-founder and COO of Oncoheroes, receiving an award in Monaco last January
Want to learn more about what Oncoheroes does? We recommend this video:
Comments